Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
11.8%  /
28.8%
7.7x
8.7x
2.7x
34.8%
69.7%
..
0.0%
27.6% 
1.1%  /
28.1%
5.1x
9.1x
2.3x
44.4%
-5.2%
..
3.4%
-2.8% 
2.0%  /
17.0%
9.8x
9.9x
3x
30.8%
-2.6%
..
4.8%
-1.8% 
-4.8%  /
16.4%
12x
37.4x
0.5x
4.2%
18.9%
2026-11-04
1.8%
21.7% 
-63.3%  /
8.4%
14.2x
9.9x
6.3x
44.0%
-87.8%
..
2.3%
-23.7% 
9.9%  /
8.0%
14.1x
14.2x
3.6x
25.6%
-18.6%
2027-02-18
3.8%
-11.1% 
7.1%  /
6.9%
13.5x
12.5x
5.2x
38.4%
-37.4%
2026-11-03
3.4%
-17.2% 
1.5%  /
6.8%
16x
15.1x
5.6x
34.9%
11.5%
..
2.9%
3.4% 
13.1%  /
6.1%
11x
11.1x
4.8x
43.5%
10.2%
..
3.5%
3.3% 
15.9%  /
5.5%
14.2x
14.1x
4.4x
30.8%
-3.8%
2026-11-07
3.0%
-1.6% 
24.0%  /
4.8%
15x
14x
5.9x
38.9%
-14.0%
2027-02-23
4.0%
-4.9% 
9.9%  /
4.6%
15.7x
13.4x
4.7x
29.5%
-22.6%
2027-02-10
3.2%
-9.7% 
1.9%  /
4.5%
13.5x
12.6x
6.1x
45.9%
-6.3%
..
3.1%
-1.8% 
-15.0%  /
4.2%
7.1x
12.1x
3.6x
49.8%
0.1%
2027-02-18
5.9%
0.1% 
8.9%  /
4.2%
14.7x
15x
5.7x
38.4%
4.2%
..
3.2%
1.2% 
0.1%  /
3.6%
12.8x
13.1x
5.8x
45.2%
-4.8%
..
3.2%
-1.4% 
-5.8%  /
3.2%
13.1x
14.1x
5.8x
43.8%
-11.8%
2026-11-06
2.7%
-3.6% 
6.2%  /
3.0%
16.6x
15.4x
7x
42.2%
-29.7%
2027-09-14
2.9%
-7.3% 
4.2%  /
3.0%
12.5x
13.9x
5x
40.1%
-17.8%
..
3.1%
-6.2% 
11.4%  /
2.8%
5.6x
12.9x
2.6x
47.5%
-0.6%
2027-02-27
0.0%
-650.0% 
10.6%  /
2.7%
12.1x
12.8x
5.1x
42.1%
-33.1%
2027-02-19
2.2%
-12.0% 
2.3%  /
1.9%
11.4x
12.8x
3.8x
33.3%
11.9%
2026-11-06
4.5%
6.4% 
-1.0%  /
1.8%
9.1x
12.8x
3.5x
38.7%
-14.4%
2027-02-12
1.5%
-14.1% 
0.6%  /
0.9%
12.1x
12.2x
4.1x
33.3%
-18.5%
..
3.5%
-8.7% 
5.0%  /
0.9%
16.8x
15.6x
6x
35.7%
-20.0%
..
3.2%
-6.0% 
-9.4%  /
0.6%
8.5x
8.1x
3.2x
38.2%
0.0%
..
3.0%
--- 
16.9%  /
0.5%
15.3x
16.3x
6.1x
39.6%
-20.0%
2027-02-19
2.4%
-4.9% 
9.5%  /
0.0%
19.2x
18.3x
10.7x
55.3%
-55.4%
2027-02-13
2.9%
-9.0% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2026-11-03
#reports #WMB

[Williams](https://eninvs.com/all.php?name=WMB) (Energy company) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=202990)
(2026-05-04, After Market Close):

- Revenue +12.3% YoY (vs +7.8% in previous quarter and historical rate +21.3%)
- EBITDA +8.5% YoY (vs +11.0% in previous quarter and historical rate +28.1%)
- EBITDA margin 54.5% decreased compared to 56.4% same period last year
- Net Debt increased by $5.2 bln since the start of the year (5.9% of market cap)
- FCF (LTM) -$2.5 bln (negative), 2.9% of market cap
- EV/EBITDA multiple is 11.9x compared to historical level (75th percentile) of 16.9x
- EV/Sales multiple is 6.8x

2026-11-03
#reports #VRTX

[Vertex Pharmaceuticals](https://eninvs.com/all.php?name=VRTX) (Pharmaceutical developer) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +11.9% YoY (vs +12.4% in previous quarter and historical rate +10.3%)
- EBITDA -38.9% YoY (vs +8.3% in previous quarter and historical rate +7.1%)
- EBITDA margin 21.6% decreased compared to 39.6% same period last year
- Net Debt increased by $6.1 bln since the start of the year (4.3% of market cap)
- FCF (LTM) +$2.4 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 31.7x compared to historical level (75th percentile) of 27.1x
- EV/Sales multiple is 11x

2026-11-03
#reports #VOYA

[Voya Financial](https://eninvs.com/all.php?name=VOYA) (Insurance company) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +0.7% YoY (vs -49.8% in previous quarter and historical rate +7.5%)
- Net Income +109.1% YoY (vs -280.6% in previous quarter and historical rate +24.1%)
- Net Income margin 12.5% increased compared to 6.0% same period last year
- P/E multiple is 30.2x compared to historical level (75th percentile) of 14.3x
- P/S multiple is 1.8x
- Price to book: 2.6x
2026-11-03
#reports #UTL

[Unitil Corporation](https://eninvs.com/all.php?name=UTL) (Public utility company) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203030)
(2026-05-04, After Market Close):

- Revenue +21.5% YoY (vs +21.9% in previous quarter and historical rate +5.1%)
- EBITDA +28% YoY (vs +29.0% in previous quarter and historical rate +10.5%)
- EBITDA margin 28.3% increased compared to 26.9% same period last year
- Net Debt increased by $22 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 3.1x

2026-11-03
#reports #UDR

[UDR](https://eninvs.com/all.php?name=UDR) (Real estate investment trust) reported for 2026 q3
(2026-02-10, After Market Close):

- Revenue -0.9% YoY (vs 0.0% in previous quarter and historical rate +2.0%)
- EBITDA +420.5% YoY (vs +224.7% in previous quarter and historical rate +65.8%)
- EBITDA margin 100.9% increased compared to 19.2% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$6.1 bln (positive), 52.9% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 6.8x

2026-11-03
#reports #TNC

[Tennant Company](https://eninvs.com/all.php?name=TNC) (Cleaning equipment manufacturer) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +6.3% YoY (vs +1.6% in previous quarter and historical rate +0.5%)
- EBITDA +24.3% YoY (vs -31.1% in previous quarter and historical rate -14.5%)
- EBITDA margin 14.3% increased compared to 12.2% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 13.7x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 1.2x

2026-11-03
#reports #SIBN

[SI-BONE](https://eninvs.com/all.php?name=SIBN) (Medical device manufacturer) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue +14.3% YoY (vs +19.1% in previous quarter and historical rate +20.2%)
- EBITDA margin -7.1% increased compared to -12.2% same period last year
- EV/Sales multiple is 2.8x

2026-11-03
#reports #RXRX

[Recursion Pharmaceuticals, Inc.](https://eninvs.com/all.php?name=RXRX) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203011)
(2026-05-06, Before Market Open):

- Revenue +35.7% YoY (vs -42.9% in previous quarter and historical rate +76.2%)
- EBITDA margin -647.4% increased compared to -685.7% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.4 bln (negative), 21.1% of market cap
- EV/Sales multiple is 18x

2026-11-03
#reports #PLTR

[Palantir Technologies](https://eninvs.com/all.php?name=PLTR) (Software provider) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +95.9% YoY (vs +92.7% in previous quarter and historical rate +52.3%)
- EBITDA +173.7% YoY (vs +233.3% in previous quarter and historical rate +158.8%)
- EBITDA margin 47.2% increased compared to 33.8% same period last year
- Net Debt increased by $6.1 bln since the start of the year (1.6% of market cap)
- FCF (LTM) +$10.3 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 106.7x compared to historical level (75th percentile) of 516.3x
- EV/Sales multiple is 49.9x

2026-11-03
#reports #PAY

[Paymentus Holdings, Inc.](https://eninvs.com/all.php?name=PAY) (Information Technology Services) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +19.6% YoY (vs +28.9% in previous quarter and historical rate +35.2%)
- EBITDA +43.3% YoY (vs +61.5% in previous quarter and historical rate +64.5%)
- EBITDA margin 11.6% increased compared to 9.6% same period last year
- Net Debt decreased by $31 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 25.9x compared to historical level (75th percentile) of 47.7x
- EV/Sales multiple is 2.8x

2026-11-03
#reports #OGS

[ONE Gas](https://eninvs.com/all.php?name=OGS) (Gas provider) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +3.2% YoY (vs -2.8% in previous quarter and historical rate -0.4%)
- EBITDA +10.6% YoY (vs +5.3% in previous quarter and historical rate +7.8%)
- EBITDA margin 40.2% increased compared to 37.5% same period last year
- Net Debt increased by $825 mln over the past reporting period (16.5% of market cap)
- FCF (LTM) -$0.3 bln (negative), 6.3% of market cap
- EV/EBITDA multiple is 22x compared to historical level (75th percentile) of 21.5x
- EV/Sales multiple is 7.6x

2026-11-03
#reports #NBIX

[Neurocrine Biosciences](https://eninvs.com/all.php?name=NBIX) (Therapeutic developer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203044)
(2026-05-05, After Market Close):

- Revenue +41.3% YoY (vs +39.4% in previous quarter and historical rate +41.9%)
- EBITDA +37.6% YoY (vs +4.0% in previous quarter and historical rate +65.6%)
- EBITDA margin 30.0% decreased compared to 30.8% same period last year
- Net Debt decreased by $358 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$1.8 bln (negative), 12.6% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 2.4x

2026-11-03
#reports #LITE

[Lumentum](https://eninvs.com/all.php?name=LITE) (Optical and photonic products provider) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +136.5% YoY (vs +109.1% in previous quarter and historical rate +41.6%)
- EBITDA +511.6% YoY (vs +498.1% in previous quarter and historical rate +88.9%)
- EBITDA margin 33.4% increased compared to 12.9% same period last year
- Net Debt decreased by $143 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$3.6 bln (positive), 7.7% of market cap
- EV/EBITDA multiple is 44.7x compared to historical level (75th percentile) of 623.1x
- EV/Sales multiple is 12.5x

2026-11-03
#reports #KFFB

[Kentucky First Federal Bancorp](https://eninvs.com/all.php?name=KFFB) (Banks — Regional) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue +50% YoY (vs +50.0% in previous quarter and historical rate +16.7%)
- P/E multiple is 14.5x compared to historical level (75th percentile) of 37x
- P/S multiple is 3.7x
- Price to book: 0.9x
2026-11-03
#reports #ICHR

[Ichor](https://eninvs.com/all.php?name=ICHR) (Semiconductor Equipment and Materials) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +37.7% YoY (vs +22.9% in previous quarter and historical rate +8.5%)
- EBITDA margin 9.1% increased compared to -5.0% same period last year
- Net Debt increased by $20 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/EBITDA multiple is 26x compared to historical level (75th percentile) of 168.3x
- EV/Sales multiple is 1.2x

2026-11-03
#reports #HLIT

[Harmonic](https://eninvs.com/all.php?name=HLIT) (Communication Equipment) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue +4.9% YoY (vs -3.6% in previous quarter and historical rate -2.2%)
- EBITDA +123.1% YoY (vs +271.4% in previous quarter and historical rate +56.4%)
- EBITDA margin 19.5% increased compared to 9.2% same period last year
- Net Debt increased by $13 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 13.2% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 37.8x
- EV/Sales multiple is 2x

2026-11-03
#reports #FN

[Fabrinet](https://eninvs.com/all.php?name=FN) (Electronic Components) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +50.7% YoY (vs +44.6% in previous quarter and historical rate +24.8%)
- EBITDA +55.6% YoY (vs +51.0% in previous quarter and historical rate +26.3%)
- EBITDA margin 11.4% increased compared to 11.0% same period last year
- Net Debt decreased by $330 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0.3 bln (negative), 2.5% of market cap
- EV/EBITDA multiple is 18x compared to historical level (75th percentile) of 35.5x
- EV/Sales multiple is 2.1x

2026-11-03
#reports #EBS

[Emergent BioSolutions](https://eninvs.com/all.php?name=EBS) (Medicines developer) reported for 2026 q3
(2026-04-30, After Market Close):

- Revenue -52.4% YoY (vs +66.0% in previous quarter and historical rate -9.3%)
- EBITDA -116% YoY (vs -504.0% in previous quarter and historical rate +5.1%)
- EBITDA margin -14.5% decreased compared to 43.3% same period last year
- Net Debt decreased by $110 mln over the past reporting period (33.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.8% of market cap
- EV/Sales multiple is 1x

2026-11-03
#reports #CWH

[Camping World](https://eninvs.com/all.php?name=CWH) (Camping retailer) reported for 2026 q3
(2026-02-24, After Market Close):

- Revenue -12.3% YoY (vs -2.1% in previous quarter and historical rate -1.8%)
- EBITDA -335.2% YoY (vs -24.7% in previous quarter and historical rate -17.3%)
- EBITDA margin -15.6% decreased compared to 5.8% same period last year
- Net Debt increased by $2.3 bln since the start of the year (652.0% of market cap)
- FCF (LTM) +$2.6 bln (positive), 737.2% of market cap
- EV/Sales multiple is 0.6x

2026-11-03
#reports #CVGI

[Commercial Vehicle Group](https://eninvs.com/all.php?name=CVGI) (Auto Parts) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=202997)
(2026-05-05, After Market Close):

- Revenue +36.8% YoY (vs +13.4% in previous quarter and historical rate -8.7%)
- EBITDA +81.8% YoY (vs +25.0% in previous quarter and historical rate +33.0%)
- EBITDA margin 9.6% increased compared to 7.2% same period last year
- EV/EBITDA multiple is 3.5x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 0.2x

2026-11-03
#reports #CRSP

[CRISPR Therapeutics](https://eninvs.com/all.php?name=CRSP) (Biological genetically engineered drugs manufacturer ) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=203015)
(2026-05-04, After Market Close):

- Revenue +1200% YoY (vs +3500.0% in previous quarter and historical rate +75.1%)
- EBITDA margin -969.2% increased compared to -13200.0% same period last year
- Net Debt increased by $187 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.8% of market cap
- EV/Sales multiple is 15.3x